Conclusions
Therefore, CIV can assist in attaining the target concentrations of
vancomycin more quickly in critically ill children, without increasing
the dosage. Also, the children subjected to CIV demonstrated no
difference in clinical efficacy and the rate of drug-related
nephrotoxicity.